José Seijas‐Amigo

Mid-range Ejection Fraction Does Not Permit Risk Stratification Among Patients Hospitalized for Heart Failure

Inés Gómez‐Otero, Andreu Ferrero‐Gregori, Alfonso Varela‐Román et al. · Revista Española de Cardiología (English Edition) · 2016 · 56 citations

Heart Failure, Cardiovascular Disease, Patient Safety +7

Prevention of myocardial infarction and stroke with PCSK9 inhibitors treatment: a metanalysis of recent randomized clinical trials

Alberto Cordero, Moisés Rodríguez‐Mañero, Lorenzo Fácila et al. · Journal of Diabetes & Metabolic Disorders · 2020 · 30 citations · Full text

Thrombosis, Cardiovascular Disease, Pharmacology +8

Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry

Alberto Cordero, María Rosa Fernández Olmo, Gustavo Aníbal Cortez Quiroga et al. · Journal of Cardiovascular Pharmacology · 2022 · 30 citations

Proposal of a novel clinical score to predict heart failure incidence in long-term survivors of acute coronary syndromes

Moisés Rodríguez‐Mañero, Alberto Cordero, Omar Kreidieh et al. · International Journal of Cardiology · 2017 · 26 citations

Heart Failure, Cardiorenal Syndromes, Cardiovascular Epidemiology +12

The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats

Alana Aragón‐Herrera, Sandra Moraña‐Fernández, Manuel Otero-Santiago et al. · Biomedicine & Pharmacotherapy · 2023 · 26 citations · Full text